Prochlorperazine 5mg tablets

Страна: Велика Британія

мова: англійська

Джерело: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активний інгредієнт:

Prochlorperazine maleate

Доступна з:

Alliance Healthcare (Distribution) Ltd

Код атс:

N05AB04

ІПН (Міжнародна Ім'я):

Prochlorperazine maleate

Дозування:

5mg

Фармацевтична форма:

Oral tablet

Адміністрація маршрут:

Oral

Клас:

No Controlled Drug Status

Тип рецепту:

Valid as a prescribable product

Огляд продуктів:

BNF: 04060000

інформаційний буклет

Prochlorperazine Tablets
SAME SIZE ARTWORK
430 x 140 mm
Front
50 mm
430 mm
140 mm
IXXXXXX
PACKAGE LEAFLET: INFORMATION FOR THE USER
PROCHLORPERAZINE 5 MG TABLETS
(PROCHLORPERAZINE MALEATE)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their
signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed
in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1. What Prochlorperazine Tablets are and what they are used for
2. What you need to know before you take Prochlorperazine Tablets
3. How to take Prochlorperazine Tablets
4. Possible side effects
5. How to store Prochlorperazine Tablets
6. Contents of the pack and other information
1. WHAT PROCHLORPERAZINE TABLETS ARE AND WHAT THEY ARE USED FOR
Prochlorperazine Tablets contain a medicine called Prochlorperazine
maleate. This belongs to a group of medicines
called ‘phenothiazine antipsychotics’. It works by blocking the
effects of a chemical in the brain. Prochlorperazine
Tablets can be used to:
•
Treat balance problems or dizziness (vertigo). This includes problems
of the inner ear such as ‘Meniere’s
Syndrome’or ‘labyrinthitis’
•
Stop you feeling sick (nausea) or being sick (vomiting). This can be
from any cause including migraines
•
Treat schizophrenia
•
Treat over-active behaviour or thoughts (mania)
•
Treat anxiety in the short-term, when used in addition to other
medicines
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE PROCHLORPERAZINE TABLETS
DO NOT TAKE THIS MEDICINE AND TELL YOUR DOCTOR IF:
•
You are allergic (hypersensitive) to Prochlorperazine maleate or any
of the other ingredients of Prochlorperazine
Tablets (listed in Section 6) Signs of a

Характеристики продукта

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Prochlorperazine maleate 5 mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each uncoated tablet contains 5 mg of prochlorperazine maleate
It also contains 103 mg lactose monohydrate.
For a full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Tablet.
White to off white coloured, circular shaped biconvex tablets, with
monogram
P5 on one side and plain on the other side.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Vertigo due to Meniere's Syndrome, labyrinthis and other causes, and
for
nausea and vomiting from whatever cause including that associated with
migraine. It may also be used for schizophrenia (particularly in the
chronic
stage), acute mania and as an adjunct to the short-term management of
anxiety.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
ADULTS
INDICATION
DOSAGE
Prevention of
nausea and
vomiting
5 to 10 mg twice or three times a day.
Treatment of
nausea and
vomiting
20 mg immediately, followed if necessary by
10 mg two hours later.
Vertigo and
5 mg three times a day increasing if necessary
INDICATION
DOSAGE
Meniere's
syndrome
to a total of 30 mg daily. After several weeks
dosage may be reduced gradually to 5-10 mg
daily.
Adjunct in the
short term
management of
anxiety
15-20 mg daily in divided doses initially but
this may be increased if necessary to a
maximum of 40 mg daily in divided doses.
Schizophrenia
and other
psychotic
disorders
Usual effective daily oral dosage is in the
order of 75-100 mg daily. Patients vary
widely in response. The following schedule is
suggested: Initially 12.5 mg twice daily for 7
days, the daily amount being subsequently
increased 12.5 mg at 4 to 7 days interval until
a satisfactory response is obtained. After
some weeks at the effective dosage, an
attempt should be made reduce this dosage.
Total daily amounts as small as 50 mg or
even 25 mg have sometimes been found to be
effective.
PAEDIATRIC POPULATION
INDICATION
DOSAGE
Prevention and
treatment of nausea
and vomiting
If it i